<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Dopamine</id>
	<title>Dopamine - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://scemsprotocols.com/scems/index.php?action=history&amp;feed=atom&amp;title=Dopamine"/>
	<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Dopamine&amp;action=history"/>
	<updated>2026-04-05T06:23:23Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.44.0</generator>
	<entry>
		<id>https://scemsprotocols.com/scems/index.php?title=Dopamine&amp;diff=1310&amp;oldid=prev</id>
		<title>Treloars: Created page with &quot;==Section 8 - MEDICATION GUIDELINES== ===ADRENERGICS===  ====Dopamine (INTROPIN) / Sympathomimetic==== &#039;&#039;&#039;DESCRIPTION&#039;&#039;&#039; * A beta agonist that does not appreciably increase my...&quot;</title>
		<link rel="alternate" type="text/html" href="https://scemsprotocols.com/scems/index.php?title=Dopamine&amp;diff=1310&amp;oldid=prev"/>
		<updated>2020-04-22T19:52:16Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;quot;==Section 8 - MEDICATION GUIDELINES== ===ADRENERGICS===  ====Dopamine (INTROPIN) / Sympathomimetic==== &amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039; * A beta agonist that does not appreciably increase my...&amp;quot;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;==Section 8 - MEDICATION GUIDELINES==&lt;br /&gt;
===ADRENERGICS===&lt;br /&gt;
&lt;br /&gt;
====Dopamine (INTROPIN) / Sympathomimetic====&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DESCRIPTION&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* A beta agonist that does not appreciably increase myocardial oxygen consumption.&lt;br /&gt;
* It maintains renal and mesenteric blood flow while inducing vasoconstriction and increasing blood pressure at doses &amp;lt; 10 mcg / kg / minute.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;INDICATIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Cardiogenic shock and hypovolemic shock after fluid resuscitation.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;CONTRAINDICATIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Hypotension due to hypovolemia without aggressive fluid resuscitation.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;PRECAUTIONS&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* Tachyarrhythmias and Ventricular Fibrillation or irritability. May be deactivated by alkaline solutions.&lt;br /&gt;
* The blood pressure should be constantly monitored.&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;DOSAGE&amp;#039;&amp;#039;&amp;#039;&lt;br /&gt;
* 5 -20 mcg / kg / minute IV piggyback - titrated to systolic BP &amp;gt;90 mm Hg. Refer to Handtevy System for pediatric dosage.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Medication Guidelines|Dopamine]]&lt;/div&gt;</summary>
		<author><name>Treloars</name></author>
	</entry>
</feed>